Siadak; Anthony W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Siadak; Anthony W..The latest application filed is for "use of il-31 monoclonal antibodies for treating prurigo nodularis".

Company Profile

6.33.35

Siadak; Anthony W. - Seattle WA
Siadak; Anthony W. - Kent WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Il-31 Monoclonal Antibodies For Treating Prurigo Nodularis App 20190374637 - Siadak; Anthony W. ; et al.	2019-12-12
Use of IL-31 monoclonal antibodies for treating pruritus Grant 10,434,173 - Siadak , et al. O	2019-10-08
Polynucleotides Encoding Il-31 Monoclonal Antibodies App 20190144533 - Siadak; Anthony W. ; et al.	2019-05-16
Use of IL-31 monoclonal antibodies for reducing pruritus Grant 10,273,297 - Siadak , et al.	2019-04-30
Methods of treating atopic dermatitis with IL-31 monoclonal antibodies Grant 10,259,868 - Siadak , et al.	2019-04-16
Use Of Il-31 Monoclonal Antibodies For Treating Pruritus App 20190038743 - Siadak; Anthony W. ; et al.	2019-02-07
Methods of treating atopic dermatitis with IL-31 monoclonal antibodies Grant 9,878,038 - Siadak , et al. January 30, 2	2018-01-30
Use Of Il-31 Monoclonal Antibodies For Reducing Pruritus App 20170355763 - Siadak; Anthony W. ; et al.	2017-12-14
Method of reducing pruritus using IL-31 monoclonal antibodies Grant 9,822,177 - Siadak , et al. November 21, 2	2017-11-21
Methods Of Treating Atopic Dermatitis With Il-31 Monoclonal Antibodies App 20170260267 - SIADAK; ANTHONY W. ; et al.	2017-09-14
Methods Of Treating Atopic Dermatitis With Il-31 Monoclonal Antibodies App 20170182160 - Siadak; Anthony W. ; et al.	2017-06-29
Method of treating atopic dermatitis with IL-31 monoclonal antibodies Grant 9,683,037 - Siadak , et al. June 20, 2	2017-06-20
Method Of Reducing Pruritus Using Il-31 Monoclonal Antibodies App 20170129952 - SIADAK; Anthony W. ; et al.	2017-05-11
Polynucleotides encoding IL-31 monoclonal antibodies Grant 9,624,296 - Siadak , et al. April 18, 2	2017-04-18
Use Of Il-31 Monoclonal Antibodies For Treating Atopic Dermatitis App 20170044253 - Siadak; Anthony W. ; et al.	2017-02-16
IL-31 monoclonal antibodies Grant 9,512,219 - Siadak , et al. December 6, 2	2016-12-06
Il-31 Monoclonal Antibodies App 20150368336 - Siadak; Anthony W. ; et al.	2015-12-24
Polynucleotides encoding IL-31 monoclonal antibodies Grant 9,156,909 - Siadak , et al. October 13, 2	2015-10-13
Variable Region Sequences Of Il-31 Monoclonal Antibodies And Methods Of Use App 20150183869 - Siadak; Anthony W. ; et al.	2015-07-02
Variable region sequences of IL-31 monoclonal antibodies and methods of use Grant 9,011,858 - Siadak , et al. April 21, 2	2015-04-21
Il-31 Monoclonal Antibodies App 20150037331 - Siadak; Anthony W. ; et al.	2015-02-05
Anti-IL-20 antibodies and binding partners and methods of using in inflammation Grant 8,907,068 - Xu , et al. December 9, 2	2014-12-09
Polynucleotides Encoding Il-31 Monoclonal Antibodies App 20140080181 - Siadak; Anthony W. ; et al.	2014-03-20
Anti-il-22ra Antibodies App 20130315919 - XU; Wenfeng ; et al.	2013-11-28
Method of reducing pruritis using IL-31 monoclonal antibodies Grant 8,568,723 - Siadak , et al. October 29, 2	2013-10-29
Variable Region Sequences Of Il-31 Monoclonal Antibodies And Methods Of Use App 20130266562 - Siadak; Anthony W. ; et al.	2013-10-10
Methods of producing anti-IL-22RA antibodies Grant 8,536,309 - Xu , et al. September 17, 2	2013-09-17
Variable Region Sequences Of Il-31 Monoclonal Antibodies And Methods Of Use App 20130216542 - SIADAK; ANTHONY W. ; et al.	2013-08-22
Variable region sequences of IL-31 monoclonal antibodies and methods of use Grant 8,466,262 - Siadak , et al. June 18, 2	2013-06-18
Anti-il-22ra Antibodies And Binding Partners And Methods Of Using In Inflammation App 20120207761 - XU; Wenfeng ; et al.	2012-08-16
Methods Of Treatment Using Anti-il-22ra Antibodies App 20120156210 - XU; Wenfeng ; et al.	2012-06-21
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation Grant 8,163,286 - Xu , et al. April 24, 2	2012-04-24
Methods of treatment using anti-IL-22RA antibodies Grant 8,124,088 - Xu , et al. February 28, 2	2012-02-28
Variable region sequences of IL-31 monoclonal antibodies Grant 8,101,183 - Siadak , et al. January 24, 2	2012-01-24
Methods Of Using Il-31 Monoclonal Antibodies To Reduce Inflammation App 20110293514 - Siadak; Anthony W. ; et al.	2011-12-01
Methods of using IL-31 monoclonal antibodies to reduce inflammation Grant 8,017,122 - Siadak , et al. September 13, 2	2011-09-13
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation Grant 7,871,616 - Xu , et al. January 18, 2	2011-01-18
Anti-il-22ra Antibodies And Binding Partners And Methods Of Using In Inflammation App 20100210825 - XU; WENFENG ; et al.	2010-08-19
Anti-il-22ra Antibodies And Binding Partners And Methods Of Using In Inflammation App 20100111948 - Xu; Wenfeng ; et al.	2010-05-06
Variable Region Sequences Of Il-31 Monoclonal Antibodies And Methods Of Use App 20100008909 - Siadak; Anthony W. ; et al.	2010-01-14
Variable Region Sequences Of Il-31 Monoclonal Antibodies And Methods Of Use App 20090252732 - Siadak; Anthony W. ; et al.	2009-10-08
Anti-il-22ra Antibodies And Binding Partners And Methods Of Using In Inflammation App 20090220519 - Xu; Wenfeng ; et al.	2009-09-03
Methods Of Using Il-31 Monoclonal Antibodies To Reduce Inflammation App 20090220417 - Siadak; Anthony W. ; et al.	2009-09-03
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation Grant 7,537,761 - Xu , et al. May 26, 2	2009-05-26
IL-31 monoclonal antibodies Grant 7,531,637 - Siadak , et al. May 12, 2	2009-05-12
Anti-il-22ra Antibodies And Binding Partners And Methods Of Using In Inflammation App 20090074661 - Xu; Wenfeng ; et al.	2009-03-19
Anti-il-20 Antibodies And Binding Partners And Methods Of Using In Inflammation App 20080247945 - Xu; Wenfeng ; et al.	2008-10-09
Anti-il-20 Antibodies And Binding Partners And Methods Of Using In Inflammation App 20080233115 - Xu; Wenfeng ; et al.	2008-09-25
Prok2 Antagonists And Methods Of Use App 20080219985 - Thompson; Penny J. ; et al.	2008-09-11
Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies Grant 7,393,684 - Xu , et al. July 1, 2	2008-07-01
IL-31 monoclonal antibodies and methods of use App 20060275296 - Siadak; Anthony W. ; et al.	2006-12-07
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation App 20060141582 - Xu; Wenfeng ; et al.	2006-06-29
Anti-IL-20 antibodies and binding partners and methods of using in inflammation App 20060134756 - Xu; Wenfeng ; et al.	2006-06-22
Anti-IL-20 receptor antibodies and binding partners and methods of using in inflammation App 20050170468 - Xu, Wenfeng ; et al.	2005-08-04
Anti-IL-20 antibodies and binding partners and methods of using in inflammation App 20050136004 - Xu, Wenfeng ; et al.	2005-06-23
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation App 20040209330 - Xu, Wenfeng ; et al.	2004-10-21
Antibodies against human CD40 Grant 6,312,693 - Aruffo , et al. November 6, 2	2001-11-06
Methods and compositions for immunomodulation Grant 6,210,669 - Aruffo , et al. April 3, 2	2001-04-03
Antibodies against human CD40 Grant 6,051,228 - Aruffo , et al. April 18, 2	2000-04-18
Anti-CD6 ligand antibodies Grant 5,998,172 - Haynes , et al. December 7, 1	1999-12-07
Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy Grant 5,876,950 - Siadak , et al. March 2, 1	1999-03-02
Monoclonal antibody compositions cross-reactive and cross-protective against P. aeruginosa serotypes Grant 5,662,905 - Siadak , et al. September 2, 1	1997-09-02
Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production Grant 4,834,975 - Siadak , et al. May 30, 1	1989-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.